TAN Ye-ying. Advances in tumor molecular imaging with 18F-fluorothymidine PET[J]. Int J Radiat Med Nucl Med, 2007, 31(1): 6-8,20.
Citation: TAN Ye-ying. Advances in tumor molecular imaging with 18F-fluorothymidine PET[J]. Int J Radiat Med Nucl Med, 2007, 31(1): 6-8,20.

Advances in tumor molecular imaging with 18F-fluorothymidine PET

  • In recent years, 18F-fluoro-3'-deoxy-3'-L-fluorothymidine (18F-FLT) has been developed as a proliferation tracer, hnaging and measurement of proliferation with PET could provide us with a non-invasive tool to value tumor cell proliferation rate and to monitor the response to anticancer treatment. In this review, the basis of 18F-FLT as a proliferation tracer is discussed. Furthermore, an overview of the current status of 18F-FLT PET research is given. The results of research show that 18F-FLT PET can correctly reflect cellular proliferation, it also has certain limitations. In comparisonwith 18F-FDG, 18F-FLT uptake is lower in most cases. Furthermore, 18F-FLT uptake does not reflect all kinds of cell proliferation.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return